Peer Review History
| Original SubmissionMarch 26, 2023 |
|---|
|
PONE-D-23-09106Aged Versus Young Gut Microbiota Transplants to Young Germ-free C57BL/6 Mice: Changes in the Reduction-Oxidation (Redox) State in the Heart and LiverPLOS ONE Dear Dr. Zhang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Both reviewers request experimental clarifications, rationale for some study design, and major revisions of text. Please note that a revised manuscript will be sent back to the same reviewers. Please submit your revised manuscript by Jul 17 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, David M. Ojcius Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: The name of the colleague or the details of the professional service that edited your manuscript A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) A clean copy of the edited manuscript (uploaded as the new *manuscript* file) 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Thank you for stating the following financial disclosure: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. Thank you for stating the following in the Acknowledgments Section of your manuscript: "This research was supported by the Basic Research Project of Sichuan Province (2022JDKY0013)." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 6. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 7. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Aged Versus Young Gut Microbiota Transplants to Young Germ-free C57BL/6 Mice: Changes in the Reduction-Oxidation (Redox) State in the Heart and Liver The authors present an interesting manuscript looking at FMT of aged microbiome into you and aged germ free mice. There are several issues with the manuscript that will require a lot of work. Major Why was aged microbiome used as FMT material? There is no rationale or translational validity to this experiment that I can see. There is no clear hypothesis that I can see. The study is underpowered, was a power calculation performed? The grammar throughout needs revision. Show graphs rather than tables for the redox experiments. Include individual data points. The authors need to discuss why they looked at the heart and the liver, there is not rationale introduced in the introduction. Please give a rationale for why only male mice were used. Were the mice germ free on purchase? What was the rationale for the time of administration of the FMT, was it administered at the same time every day? line 91, OUT spelt wrong. What was the statistical method for analysing microbiome? Line 98 is confusing, 4th week of what? How was the serum compared? More details of the methods for redox analysis are needed Reviewer #2: The study investigates the effects of gut microbiota on the redox state in two important organs such as heart and liver. In particular, they used FMT mouse-to-mouse approach using two different types of donors: aged and young. The recipients of the FMT were young germ-free mice. They evaluated the engraftment of the gut microbiota after the FMT and also the redox state in heart and liver. The work is interesting. However, the paper could be improved doing some major corrections. Taken together, the paper could be acceptable for publication only if the comments are addressed, as needs a big change. Please read my comments: 1. Title: In my opinion, the title is too long. For example, use only Germ-Free and indicate that you use C57BL/6 in the body of the paper. Choose between Reduction-Oxidation or Redox, as sound redundant. Perhaps, you can create a more informative title rather than a descriptive title. 2. Abstract: The abstract needs more work as is not clear on the objectives, the methods and the results are not clear. For example, in the line 9 the acronym GM is not clear if refers to age gut microbiota or just gut microbiota, so this makes a bit confusing the rest of the reading. Another example is that the reason of why the study was performed is not clear. 3. Introduction: a. Lines 32-34, this refers to FMT studies? What are the characteristics of the aging in rat brain and mice intestine? b. Line 49: Why is important or interesting to evaluate Redox state in heart and liver? c. Line 53: As the term reduction-oxidation has been associated with the acronym redox, use that throughout the manuscript, as can be confusing to read it all the time. 4. Material and Methods: a. Mice: Just wondering why only males were used in the study? Is there a prevalence in alteration of the redox state in a male population rather than the females? You purchase the mice at 4 weeks old and then performed the experiments at 5 weeks old, which to my understanding correspond to adolescence period, so you might clarify that you are doing and intervention in the adolescence and the readouts are in adulthood. The term “young” is not clear and is important to mention that the intervention was performed during adolescence as many processes are still on going. b. FMT: Is the FMT procedure performed as one-to-one mouse? c. Redox state analysis: Can the isoflurane influence the redox state in the tissue analysed? Performing only cervical dislocation was not an option? In general, this section needs more attention, a brief explanation on how each analysis was performed would improve the paper. 5. Results: a. Figures: Please provide a more elaborated figure legend for ach figure. b. Figure 3: Elaborate the legend in terms of what * means, what are the error bars SD or SEM? Add more info to the letters used like A) Shannon, B) Simpson. This will help the reader to better understand the data. c. Redox data: Perhaps having the data in graphs instead of table might help the reader to visualise the findings. As there are quite a lot of results, this can be clustered in panels. In general, the figures need to be made in a better image quality. Ignore these comments if the image quality was affected during the PDF exportation process. 6. Discussion: The begging of the discussion need rephrasing as is confusing. a. Line 167: What about the MDA levels in GF mice? Is this parameter already altered in the model? Please add discussion around this. b. Line 172: Please elaborate on how and what future work should be performed. c. Line 174: O2 and OH terms has not been used before so can be confusing to the reader to interpret the provided discussion. Please clarify this throughout the manuscript. d. Line 179: Please elaborate regarding the importance or relevance of the increased rate of free radicals in the aged-FMT, what this mean? e. Lines 198-200: Is the gut microbiota involved in this process? In general, there is a very little information about the gut microbiota in the manuscript and why this type of intervention was chosen. In the introduction should be more info about the microbiota and why the FMT approach was used. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Gerard Moloney Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Aged Gut Microbiota Contribute to Different Changes in Antioxidant Defense in the Heart and Liver after Transfer to Germ-free Mice PONE-D-23-09106R1 Dear Dr. Zhang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, David M. Ojcius Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have done a very good job of anwering all of the questions I had. Once the amendments are finalised, this paper is ready for publication. Reviewer #2: The authors of the manuscript titled "Aged Gut Microbiota Contribute to Different Changes in Antioxidant Defense in the Heart and Liver after Transfer to Germ-free Mice" addressed all my comments. I believe the paper is good to be published. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Gerard Moloney Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-23-09106R1 Aged Gut Microbiota Contribute to Different Changes in Antioxidant Defense in the Heart and Liver after Transfer to Germ-free Mice Dear Dr. Zhang: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. David M. Ojcius Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .